Notable Decliners: salesforce.com, inc. (NYSE:CRM), Liquid Holdings Group Inc (NASDAQ:LIQD), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Zogenix, Inc. (NASDAQ:ZGNX)

salesforce.com, inc. (NYSE:CRM), the biggest maker of customer-management software, forecast second-quarter sales that exceeded analysts’ predictions as the company’s Web-based products continue to lure new users. Revenue in the quarter ending in July will be about $1.29 billion, the San Francisco-based company said yesterday in a statement. salesforce.com, inc. (NYSE:CRM) stock performance was -5.10% in last session and finished the day at $50.19. Traded volume … Continue reading Notable Decliners: salesforce.com, inc. (NYSE:CRM), Liquid Holdings Group Inc (NASDAQ:LIQD), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Zogenix, Inc. (NASDAQ:ZGNX)

Bearish Stocks: Inovio Pharmaceuticals Inc (NYSEMKT:INO), BroadSoft Inc (NASDAQ:BSFT), KBR (NYSE:KBR), Ballard Power Systems (NASDAQ:BLDP)

Inovio Pharmaceuticals (NYSE:INO)’s shares were the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 28,830,223 shares, a decline of 2.1% from the March 31st total of 28,233,502 shares, Analyst Ratings News reports.Inovio Pharmaceuticals Inc (NYSEMKT:INO)stock performance was -6.25% in last session and finished the day at $ 2.40. Traded volume was 5.94 million shares … Continue reading Bearish Stocks: Inovio Pharmaceuticals Inc (NYSEMKT:INO), BroadSoft Inc (NASDAQ:BSFT), KBR (NYSE:KBR), Ballard Power Systems (NASDAQ:BLDP)

Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -2.62% in last session and finished the day at $2.60. Traded volume was 16.17million shares in the last … Continue reading Investor’s Alert: Inovio Pharmaceuticals (NYSEMKT:INO), Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Agios Pharmaceuticals (NASDAQ:AGIO)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) announced the appointment of E.J. Brandreth as vice president of quality. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -5.71% in last session and finished the day at $3.14. Traded volume was 9.33million shares in the last session and the average volume of the stock remained 7.54million shares. The beta of the stock remained 3.71. Inovio Pharmaceuticals Inc (NYSEMKT:INO) insider ownership is … Continue reading Small CAp Active Runners: Inovio Pharmaceuticals (NYSEMKT:INO), Walter Energy (NYSE:WLT), EXACT Sciences Corporation (NASDAQ:EXAS), Western Asset Mortgage Capital (NYSE:WMC)

An FDA report raised questions regarding Mannkind Corporation (NASDAQ:MNKD)’s diabetes device Afrezza ahead of an April 1 meeting of outside advisers to the FDA. The drug has yet to be approved by the FDA as there are concerns over certain pharmacology issues that could impact Afreeza’s safety and effectiveness. MannKind Corporation (NASDAQ:MNKD) stock performance was -7.12% in last session and finished the day at $4.83. … Continue reading Biotech Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Exelixis (NASDAQ:EXEL), Inovio Pharmaceuticals (NYSEMKT:INO), EXACT Sciences (NASDAQ:EXAS)

Trade-Ideas LLC identified Inovio Pharmaceuticals Inc (NYSEMKT:INO) as a “barbarian at the gate” (strong stocks crossing above resistance with today’s range greater than 200%) candidate. Inovio Pharmaceuticals, Inc. (NYSEMKT:INO), together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Currently there are 3 analysts that rate Inovio Pharmaceuticals Inc (NYSEMKT:INO) a buy, no … Continue reading Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)